Yazar "Pasa, S." seçeneğine göre listele
Listeleniyor 1 - 20 / 25
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe THE ASSOCIATION BETWEEN METABOLIC REGULATION OF PATIENTS WITH DIABETES AND PHACOEMULCIFICATION INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS(Wichtig Publ, 2015) Pasa, S.; Balyen, L.; Balyen, L. S. D.; Satic, O.[Abstract Not Available]Öğe COMPARISON OF EFFECTS OF INTRAVITREAL VERSUS POSTERIOR SUBTENON TRIAMCINOLONE ACETONIDE INJECTION ON INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA(Wichtig Publ, 2015) Atay, A. E.; Balyen, L.; Balyen, L. S. D.; Pasa, S.; Satici, O.[Abstract Not Available]Öğe THE EFFECTS OF OBESITY, DIABETIC REGULATION, HYPERLIPIDAEMIA AND INSULIN PREPARATION ON DIABETIC RETINOPATHY(Wichtig Publ, 2015) Balyen, L. S. D.; Balyen, L.; Pasa, S.; Satici, O.[Abstract Not Available]Öğe Efficacy of recombinant FVIIA treatment in inhibitor positive hemophilic patients and in Glanzmann thrombasthenia: Single center experience(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Urakci, Z.; Muftuoglu, O. E.; Cil, T.[Abstract Not Available]Öğe THE EFFICACY OF RITUXIMAB IN PATIENTS WITH SPLENECTOMIZED REFRACTORY CHRONIC IDIOPATHIC THROMBOCYTHOPENIC PURPURA(Ferrata Storti Foundation, 2008) Pasa, S.; Altintas, A.; Cil, T.; Danis, R.; Ayyildiz, O.[Abstract Not Available]Öğe EVALUATION OF DEPRESSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC RETINOPATHY(Wichtig Publ, 2015) Balyen, L.; Balyen, L. S. D.; Pasa, S.; Satici, O.[Abstract Not Available]Öğe Evaluation of endothelial function in patient with Sheehans syndrome and the effect of hormone replacement treatment except growth hormone on endothelial dysfunction(Ferrata Storti Foundation, 2007) Pasa, S.; Altintas, A.; Can, A.; Sayar, S.[Abstract Not Available]Öğe Evaluation of Hepatitis B Viraemia Levels in Patients with HBeAg-negative Chronic Hepatitis B Virus Infection(Sage Publications Ltd, 2012) Atay, A. E.; Seven, G.; Yalcin, K.; Pasa, S.; Degertekin, H.OBJECTIVES: To evaluate patients with chronic hepatitis B virus (HBV) infection and low-level viraemia in terms of determining HBV DNA cut-off values and levels of alanine aminotransferase (ALT) and other possible markers for discriminating between chronic hepatitis B e-antigen (HBeAg)-negative patients and hepatitis B surface antigen (HBsAg) inactive carriers. METHODS: HBV-infected patients who were HBeAg-negative with undetectable HBV DNA by standard hybridization assay and high (HBeAg-negative group, n = 81) or normal (HBsAg inactive carrier group, n = 77) ALT levels were enrolled. Quantitative polymerase chain reaction assay using a COBAS Amplicor HBV monitor test was performed to detect low HBV DNA levels. RESULTS: The HBV DNA level was found to be significantly higher in the HBeAg-negative chronic HBV group (mean +/- SD 94 477 +/- 167 528 copies/nil) compared with the HBsAg inactive carrier group (mean +/- SD 19 215 +/- 57 970 copies/ml). CONCLUSIONS: A low level of viral replication may persist in chronic HBV-infected patients who are HBeAg-negative, and the level of HBV DNA was higher in the HBeAg-negative group than in the inactive HBsAg carrier group. Necroinflammation also persisted in the HBeAg-negative group and these patients had a higher level of ALT than the inactive HBsAg carriers.Öğe EVALUATION OF SEXUAL DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND DIABETIC RETINOPATHY(Wichtig Publ, 2015) Gokalp, D.; Balyen, L.; Balyen, L. S. D.; Pasa, S.; Satici, O.[Abstract Not Available]Öğe Factor V leiden and G20210A prothrombin mutations in patient with recurrent pregnancy loss: Data from southeast of Turkey(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Ayyildiz, O.; Cil, T.[Abstract Not Available]Öğe Hepatitis B and C viruses seroprevalence of cancer patients in southeastern region of Turkey(Pergamon-Elsevier Science Ltd, 2007) Cil, T.; Altintas, A.; Pasa, S.; Kaplan, M.; Isikdogan, A.[Abstract Not Available]Öğe Hereditary hemochromatosis gene mutations in the south eastern region of Turkey(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Cil, T.; Devecioglu, B.; Ayyildiz, O.[Abstract Not Available]Öğe Hirsutism Score and the Severity of Hyperandrogenism Associated with Polycystic Ovary Syndrome in the South-eastern Region of Turkey(Sage Publications Ltd, 2011) Demir, B.; Pasa, S.; Demir, S.; Tumer, C.; Atay, A. E.; Gul, T.; Atamer, Y.This study investigated the severity of hirsutism and its correlation with serum total testosterone (tT) levels in 87 patients with polycystic ovary syndrome (PCOS) and 85 healthy control subjects from the south-eastern region of Turkey. A wide range of variability exists in both hirsutism and modified Ferriman-Gallwey (mFG) scores. Similar mFG scores and serum tT levels were found compared with previous studies of general populations, but lower scores than those previously reported from Turkey. The incidence of hirsutism was lower in hyperandrogenic PCOS patients compared with nonhyperandrogenic PCOS patients. There was no correlation between serum tT levels and the rate of hirsutism in patients with PCOS. Heritability, testosterone receptor sensitivity, 5 alpha reductase activity or environmental/socioeconomic factors may play a role in the development of clinical hirsutism. Larger scale studies are needed to clarify which other factors may be responsible and to confirm these results.Öğe Inhibitors in hemophilia A and B in Souteast of Turkey(Ferrata Storti Foundation, 2007) Pasa, S.; Altintas, A.; Cil, T.; Atayan, Y.; Ayyildiz, O.[Abstract Not Available]Öğe Morphologic and functional vascular alterations in patients with polycystic ovary syndrome(I R O G Canada, Inc, 2011) Demir, B.; Pasa, S.; Demir, S.; Buyukkaya, R.; Atay, A. E.; Atamer, Y.; Gul, T.Background: We aimed to investigate morphologic and functional alterations of common carotid arteries (CCA) and femoral arteries and the anteroposterior diameter of the abdominal aorta in patients with polycystic ovary syndrome (PCOS). Materials and Methods: Fifty consecutive females with the complaint of oligoamenorrhea, infertility or hirsutismus, diagnosed with PCOS and 50 healthy females admitted to the Department of Gynecology and Obstetrics, Ergani State Hospital between January 2010 and January 2011 were included in the study. Results: The mean BMI of 50 patients with PCOS was higher than control subjects (CS) (25.89 +/- 3.3 vs 22.52 +/- 2.7 kg/m(2), p < 0.0001). The mean arterial blood pressure was 88.93 +/- 6.4 mmHg in the patient group and was it 85.73 +/- 7.6 mmHg in CS (p = 0.02). The mean plasma glucose level (74.04 +/- 6.7 vs 70.5 +/- 6.4 mg/dl), total cholesterol level (167.88 +/- 30.1 vs 153.38 +/- 27.8 mg/di), low density lipoprotein level (101.28 +/- 27.0 vs 79.56 +/- 25.5 mg/dl) and triglyceride level (121.22 +/- 49.2 vs 102.54 +/- 36.6 mg/di) were higher; also the mean high density lipoprotein level (44.56 +/- 8.1 vs 50.90 +/- 12.3 mg/dl) was lower in patients with PCOS than CS (p = 0.009, p = 0.014, p < 0.0001, p = 0.034 and p = 0.003, respectively). CCA-IMT (0.63 +/- 0.2 vs 0.52 +/- 0.1 mm), and CCA-PI (1.44 +/- 0.3 vs 1.28 +/- 0.22) were higher in patients with PCOS (p = 0.018 and p = 0.005, respectively). Femoral-IMT (0.62 +/- 0.6 vs 0.41 +/- 0.1 mm) and anteroposterior diameter of the infrarenal aorta (12.34 +/- 1.5 vs 11.4 +/- 1.0 mm) were higher in patients with PCOS (p = 0.024 and p = 0.001, respectively). Conclusion: The present study showed that IMT and PI of CCA, and anteroposterior diameter of the infrarenal abdominal aorta and femoral-IMT were higher in patients with PCOS. These results are probably related with increased androgens, their effects on insulin resistance and lipid profile, increased BMI and blood pressure. Detection of these functional and/or structural abnormalities are important in predicting prognosis. Larger scale prospective studies are needed to determine the effects of PCOS on the mortality and morbidity, and to clarify the relation between the duration of the disease and development of these alterations.Öğe NT-Probnp levels to perspectively assess acut cardiac failure after adjuvant doxorubicine therapy in early breast cancer patients(Amer Soc Clinical Oncology, 2008) Cil, T.; Altintas, A.; Pasa, S.; Kaplan, M. A.; Alan, S.; Isikdogan, A.[Abstract Not Available]Öğe Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Ozel, A.; Okur, N.; Okur, N.[Abstract Not Available]Öğe PREVALENCE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES POSITIVITY IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA(Oxford Univ Press, 2008) Cil, T.; Altintas, A.; Pasa, S.; Isikdogan, A.[Abstract Not Available]Öğe Pulmonary hypertension in essential thrombocythemia(Ferrata Storti Foundation, 2007) Altintas, A.; Boyraz, T.; Pasa, S.; Cil, T.; Kaplan, M. A.; Ayyildiz, O.[Abstract Not Available]Öğe The relation between chronic idiopathic thrombocytopenic purpura and thyroid autoantibodies(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Parmaksiz, E.[Abstract Not Available]
